KK8398

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KK8398, covering 2025-04-29 to 2025-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study） [Phase 3]